Danaher Other Non-Current Liabilities 2010-2024 | DHR
Danaher other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Danaher other non-current liabilities for the quarter ending December 31, 2024 were $5.647B, a 12.3% decline year-over-year.
- Danaher other non-current liabilities for 2023 were $6.017B, a 7.4% decline from 2022.
- Danaher other non-current liabilities for 2022 were $6.498B, a 15.6% decline from 2021.
- Danaher other non-current liabilities for 2021 were $7.699B, a 1.16% decline from 2020.
| Danaher Annual Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $6,017 |
| 2022 | $6,498 |
| 2021 | $7,699 |
| 2020 | $7,789 |
| 2019 | $5,351 |
| 2018 | $4,702 |
| 2017 | $5,161 |
| 2016 | $5,670 |
| 2015 | $5,750 |
| 2014 | $4,584 |
| 2013 | $4,257 |
| 2012 | $4,363 |
| 2011 | $3,599 |
| 2010 | $2,340 |
| 2009 | $2,315 |
| Danaher Quarterly Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024-09-30 | $5,647 |
| 2024-06-30 | $5,643 |
| 2024-03-31 | $5,760 |
| 2023-12-31 | $6,017 |
| 2023-09-30 | $6,439 |
| 2023-06-30 | $6,489 |
| 2023-03-31 | $6,563 |
| 2022-12-31 | $6,498 |
| 2022-09-30 | $7,493 |
| 2022-06-30 | $7,597 |
| 2022-03-31 | $7,715 |
| 2021-12-31 | $7,699 |
| 2021-09-30 | $8,189 |
| 2021-06-30 | $8,036 |
| 2021-03-31 | $7,905 |
| 2020-12-31 | $7,789 |
| 2020-09-30 | $7,074 |
| 2020-06-30 | $7,026 |
| 2020-03-31 | $6,661 |
| 2019-12-31 | $5,351 |
| 2019-09-30 | $5,865 |
| 2019-06-30 | $5,956 |
| 2019-03-31 | $6,115 |
| 2018-12-31 | $4,702 |
| 2018-09-30 | $5,011 |
| 2018-06-30 | $5,080 |
| 2018-03-31 | $5,090 |
| 2017-12-31 | $5,161 |
| 2017-09-30 | $5,356 |
| 2017-06-30 | $5,427 |
| 2017-03-31 | $5,722 |
| 2016-12-31 | $5,670 |
| 2016-09-30 | $5,767 |
| 2016-06-30 | $6,350 |
| 2016-03-31 | $6,293 |
| 2015-12-31 | $5,750 |
| 2015-09-30 | $6,376 |
| 2015-06-30 | $4,707 |
| 2015-03-31 | $4,675 |
| 2014-12-31 | $4,584 |
| 2014-09-30 | $4,290 |
| 2014-06-30 | $4,437 |
| 2014-03-31 | $4,287 |
| 2013-12-31 | $4,257 |
| 2013-09-30 | $4,626 |
| 2013-06-30 | $4,511 |
| 2013-03-31 | $4,389 |
| 2012-12-31 | $4,363 |
| 2012-09-30 | $4,039 |
| 2012-06-30 | $3,926 |
| 2012-03-31 | $3,754 |
| 2011-12-31 | $3,599 |
| 2011-09-30 | $4,119 |
| 2011-06-30 | $4,152 |
| 2011-03-31 | $2,319 |
| 2010-12-31 | $2,340 |
| 2010-09-30 | $2,424 |
| 2010-06-30 | $2,274 |
| 2010-03-31 | $2,347 |
| 2009-12-31 | $2,315 |
| 2009-09-30 | $2,374 |
| 2009-06-30 | $2,348 |
| 2009-03-31 | $2,355 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $148.052B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $90.846B | 11.88 |
| CVS Health (CVS) | United States | $83.717B | 12.25 |
| Cencora (COR) | United States | $47.591B | 17.27 |
| DiDi Global (DIDIY) | China | $23.087B | 0.00 |
| Natera (NTRA) | United States | $22.788B | 0.00 |
| ICON (ICLR) | Ireland | $15.783B | 14.04 |
| Doximity (DOCS) | United States | $14.316B | 74.45 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Revvity (RVTY) | United States | $13.997B | 23.47 |
| Viatris (VTRS) | United States | $13.046B | 4.02 |
| Solventum (SOLV) | United States | $12.780B | 0.00 |
| Avantor (AVTR) | United States | $12.038B | 17.68 |
| CochLear (CHEOY) | Australia | $11.471B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.479B | 27.23 |
| HealthEquity (HQY) | United States | $9.860B | 49.47 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.450B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.815B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.437B | 15.99 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.745B | 26.29 |
| Organon (OGN) | United States | $3.938B | 4.01 |
| Sotera Health (SHC) | United States | $3.861B | 20.65 |
| BrightSpring Health Services (BTSG) | United States | $3.639B | 77.41 |
| Surgery Partners (SGRY) | United States | $3.282B | 37.42 |
| GeneDx Holdings (WGS) | United States | $3.058B | 371.03 |
| Concentras Parent (CON) | United States | $2.973B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.699B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.371B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.078B | 0.00 |
| Progyny (PGNY) | United States | $2.017B | 40.85 |
| PACS (PACS) | United States | $2.006B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.955B | 51.30 |
| Premier (PINC) | United States | $1.711B | 10.96 |
| Agilon Health (AGL) | United States | $1.471B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.325B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.212B | 11.86 |
| Establishment Labs Holdings (ESTA) | $1.010B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.908B | 6.14 |
| Embecta (EMBC) | United States | $0.899B | 6.16 |
| Auna S.A (AUNA) | Luxembourg | $0.633B | 0.00 |
| DocGo (DCGO) | United States | $0.562B | 21.19 |
| Sonida Senior Living (SNDA) | United States | $0.499B | 0.00 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| MultiPlan (MPLN) | United States | $0.476B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.440B | 38.09 |
| Nutex Health (NUTX) | United States | $0.352B | 0.00 |
| LifeMD (LFMD) | United States | $0.345B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.308B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.210B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.138B | 0.00 |
| So-Young (SY) | China | $0.118B | 19.98 |
| IceCure Medical (ICCM) | Israel | $0.086B | 0.00 |
| ModivCare (MODV) | United States | $0.082B | 4.46 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| Oncology Institute (TOI) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.60 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.048B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.020B | 0.00 |
| KindlyMD (KDLY) | United States | $0.016B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |